The present invention relates to butenoic acid derivatives of the formula I: in which R, R.sup.1, R.sup.2 and R.sup.3 are as defined in the description, and also to processes for the preparation thereof, to pharmaceutical compositions comprising them and to their use for the treatment of dyslipidaemia, atherosclerosis and diabetes.